Vivos (RDGL) Total Debt (QoQ) (2012 - 2019)
Vivos (RDGL) Total Debt (QoQ) (2012 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 9,616.86% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 15.53% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | -75.03% |
| Mar 31, 2016 | 3.89% |
| Dec 31, 2015 | 21.31% |
| Sep 30, 2015 | -76.71% |
| Jun 30, 2015 | 384.24% |
| Mar 31, 2015 | -79.02% |
| Dec 31, 2014 | 770.97% |
| Sep 30, 2014 | -12.23% |
| Jun 30, 2014 | 66.74% |
| Mar 31, 2014 | -21.41% |
| Dec 31, 2013 | 25.76% |
| Sep 30, 2013 | 20.63% |
| Dec 31, 2012 | 36.78% |